Purchases and Sales Made in Q1 2024 in Recursion Pharmaceuticals, Inc. (RXRX)
This table provides information about the institutional ownership of Recursion Pharmaceuticals, Inc. (RXRX) during Q1 2024. The information is specifically focused on institutions that hold shares of RECURSION PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Dec 26, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-94.1K- 8.0% |
$859K - $1.46M
|
1.08M
$8.6M
|
|
|
May 01, 2024
Q1 2024
|
Baillie Gifford & CO
|
SELL
|
- |
-112K- 0.46% |
$1.02M - $1.73M
|
24.1M
$191M
|
|
|
May 15, 2024
Q1 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-131K- 38.15% |
$1.19M - $2.03M
|
212K
$1.69M
|
|
|
May 13, 2024
Q1 2024
|
Jefferies Financial Group Inc.
New York, NY |
SELL
|
- |
-170K- 94.38% |
$1.55M - $2.64M
|
10.1K
$80.4K
|
|
|
May 13, 2024
Q1 2024
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-200K- 18.34% |
$1.83M - $3.1M
|
890K
$7.08M
|
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-282K- 47.31% |
$2.58M - $4.38M
|
314K
$2.5M
|
|
|
Apr 29, 2024
Q1 2024
|
Principal Financial Group Inc
Des Moines, IA |
SELL
|
- |
-286K- 41.83% |
$2.61M - $4.44M
|
398K
$3.16M
|
|
|
May 15, 2024
Q1 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-295K- 24.73% |
$2.69M - $4.58M
|
897K
$7.13M
|
|
|
May 13, 2024
Q1 2024
|
Platinum Investment Management LTD
Sydney Australia 2000, C3 |
SELL
|
- |
-473K- 20.82% |
$4.32M - $7.35M
|
1.8M
$14.3M
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-612K- 23.76% |
$5.59M - $9.5M
|
1.96M
$15.6M
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-612K- 23.76% |
$5.59M - $9.5M
|
1.96M
$15.6M
|
|
|
May 15, 2024
Q1 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-1.07M- 72.75% |
$9.76M - $16.6M
|
401K
$3.19M
|
|
|
May 15, 2024
Q1 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.8M- 14.81% |
$16.4M - $27.9M
|
10.4M
$82.3M
|